Barinthus Biotherapeutics BRNS reported its Q4 earnings results on Wednesday, March 20, 2024 at 08:15 AM.
Here's what investors need to know about the announcement.
Earnings
Barinthus Biotherapeutics beat estimated earnings by 10.0%, reporting an EPS of $-0.45 versus an estimate of $-0.5.
Revenue was down $6.46 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 7.000000000000001% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Barinthus Biotherapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.